Selected research
Market Structure
Global Drug Release Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Drug Release Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Drug Release Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug Release Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Release Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Drug Release Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Drug Release Platform include Evonik, Camurus, Pacira BioSciences, Starpharma, ProLynx, Liquidia, MedinCell, Intarcia and Corium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Drug Release Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug Release Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug Release Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Release Platform market size, projected growth trends, production technologies, key applications, and end-use industries.
Drug Release Platform Segment by Company
Evonik
Camurus
Pacira BioSciences
Starpharma
ProLynx
Liquidia
MedinCell
Intarcia
Corium
Enable Injections
Alkermes
Depomed
NanoCarrier
Lyndra
Hisun Pharmaceutical
Livzon Pharmaceutical Group
Hengrui Pharmaceuticals
HEC ChangJiang Pharmaceutical
Luye Pharma
Lanna Bio
Drug Release Platform Segment by Type
Oral Sustained-Release Platform
Implantable Sustained-Release Platform
Local Sustained-Release Platform
Drug Release Platform Segment by Application
Pharmaceutical Companies
Hospitals
Others
Drug Release Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Release Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Release Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Release Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Release Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Release Platform industry.
Chapter 3: Detailed analysis of Drug Release Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Release Platformrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Sustained-Release Platform
- Implantable Sustained-Release Platform
- Local Sustained-Release Platform
Applications
- Pharmaceutical Companies
- Hospitals
- Others
Companies covered
- Evonik
- Camurus
- Pacira BioSciences
- Starpharma
- ProLynx
- Liquidia
- MedinCell
- Intarcia
- Corium
- Enable Injections
- Alkermes
- Depomed
- NanoCarrier
- Lyndra
- Hisun Pharmaceutical
- Livzon Pharmaceutical Group
- Hengrui Pharmaceuticals
- HEC ChangJiang Pharmaceutical
- Luye Pharma
- Lanna Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Drug Release Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Oral Sustained-Release Platform
- 1.2.3 Implantable Sustained-Release Platform
- 1.2.4 Local Sustained-Release Platform
- 1.3 Market Analysis by Application
- 1.3.1 Global Drug Release Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Hospitals
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Drug Release Platform Growth Trends by Region
- 1.5.1 Global Drug Release Platform Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Drug Release Platform Market Size by Region (2021-2026)
- 1.5.3 Drug Release Platform Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Drug Release Platform Market Dynamics
- 2.1 Drug Release Platform Industry Trends
- 2.2 Drug Release Platform Industry Drivers
- 2.3 Drug Release Platform Industry Opportunities and Challenges
- 2.4 Drug Release Platform Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Drug Release Platform Revenue by Company (2021-2026)
- 3.2 Global Drug Release Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Drug Release Platform Key Company Head office and Area Served
- 3.4 Global Drug Release Platform Company, Product Type & Application
- 3.5 Global Drug Release Platform Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Drug Release Platform Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Drug Release Platform Players Market Share by Revenue in 2025
- 3.6.3 2025 Drug Release Platform Tier 1, Tier 2, and Tier 3
4 Drug Release Platform Market by Type
- 4.1 Global Drug Release Platform Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Drug Release Platform Market Size by Type (2021-2032)
- 4.3 Global Drug Release Platform Market Size Share by Type (2021-2032)
5 Drug Release Platform Market by Application
- 5.1 Global Drug Release Platform Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Drug Release Platform Market Size by Application (2021-2032)
- 5.3 Global Drug Release Platform Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Evonik
- 6.1.1 Evonik Company Information
- 6.1.2 Evonik Business Overview
- 6.1.3 Evonik Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Evonik Drug Release Platform Product Portfolio
- 6.1.5 Evonik Recent Developments
- 6.2 Camurus
- 6.2.1 Camurus Company Information
- 6.2.2 Camurus Business Overview
- 6.2.3 Camurus Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Camurus Drug Release Platform Product Portfolio
- 6.2.5 Camurus Recent Developments
- 6.3 Pacira BioSciences
- 6.3.1 Pacira BioSciences Company Information
- 6.3.2 Pacira BioSciences Business Overview
- 6.3.3 Pacira BioSciences Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Pacira BioSciences Drug Release Platform Product Portfolio
- 6.3.5 Pacira BioSciences Recent Developments
- 6.4 Starpharma
- 6.4.1 Starpharma Company Information
- 6.4.2 Starpharma Business Overview
- 6.4.3 Starpharma Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Starpharma Drug Release Platform Product Portfolio
- 6.4.5 Starpharma Recent Developments
- 6.5 ProLynx
- 6.5.1 ProLynx Company Information
- 6.5.2 ProLynx Business Overview
- 6.5.3 ProLynx Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 ProLynx Drug Release Platform Product Portfolio
- 6.5.5 ProLynx Recent Developments
- 6.6 Liquidia
- 6.6.1 Liquidia Company Information
- 6.6.2 Liquidia Business Overview
- 6.6.3 Liquidia Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Liquidia Drug Release Platform Product Portfolio
- 6.6.5 Liquidia Recent Developments
- 6.7 MedinCell
- 6.7.1 MedinCell Company Information
- 6.7.2 MedinCell Business Overview
- 6.7.3 MedinCell Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 MedinCell Drug Release Platform Product Portfolio
- 6.7.5 MedinCell Recent Developments
- 6.8 Intarcia
- 6.8.1 Intarcia Company Information
- 6.8.2 Intarcia Business Overview
- 6.8.3 Intarcia Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Intarcia Drug Release Platform Product Portfolio
- 6.8.5 Intarcia Recent Developments
- 6.9 Corium
- 6.9.1 Corium Company Information
- 6.9.2 Corium Business Overview
- 6.9.3 Corium Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Corium Drug Release Platform Product Portfolio
- 6.9.5 Corium Recent Developments
- 6.10 Enable Injections
- 6.10.1 Enable Injections Company Information
- 6.10.2 Enable Injections Business Overview
- 6.10.3 Enable Injections Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Enable Injections Drug Release Platform Product Portfolio
- 6.10.5 Enable Injections Recent Developments
- 6.11 Alkermes
- 6.11.1 Alkermes Company Information
- 6.11.2 Alkermes Business Overview
- 6.11.3 Alkermes Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Alkermes Drug Release Platform Product Portfolio
- 6.11.5 Alkermes Recent Developments
- 6.12 Depomed
- 6.12.1 Depomed Company Information
- 6.12.2 Depomed Business Overview
- 6.12.3 Depomed Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Depomed Drug Release Platform Product Portfolio
- 6.12.5 Depomed Recent Developments
- 6.13 NanoCarrier
- 6.13.1 NanoCarrier Company Information
- 6.13.2 NanoCarrier Business Overview
- 6.13.3 NanoCarrier Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 NanoCarrier Drug Release Platform Product Portfolio
- 6.13.5 NanoCarrier Recent Developments
- 6.14 Lyndra
- 6.14.1 Lyndra Company Information
- 6.14.2 Lyndra Business Overview
- 6.14.3 Lyndra Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Lyndra Drug Release Platform Product Portfolio
- 6.14.5 Lyndra Recent Developments
- 6.15 Hisun Pharmaceutical
- 6.15.1 Hisun Pharmaceutical Company Information
- 6.15.2 Hisun Pharmaceutical Business Overview
- 6.15.3 Hisun Pharmaceutical Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Hisun Pharmaceutical Drug Release Platform Product Portfolio
- 6.15.5 Hisun Pharmaceutical Recent Developments
- 6.16 Livzon Pharmaceutical Group
- 6.16.1 Livzon Pharmaceutical Group Company Information
- 6.16.2 Livzon Pharmaceutical Group Business Overview
- 6.16.3 Livzon Pharmaceutical Group Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Livzon Pharmaceutical Group Drug Release Platform Product Portfolio
- 6.16.5 Livzon Pharmaceutical Group Recent Developments
- 6.17 Hengrui Pharmaceuticals
- 6.17.1 Hengrui Pharmaceuticals Company Information
- 6.17.2 Hengrui Pharmaceuticals Business Overview
- 6.17.3 Hengrui Pharmaceuticals Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Hengrui Pharmaceuticals Drug Release Platform Product Portfolio
- 6.17.5 Hengrui Pharmaceuticals Recent Developments
- 6.18 HEC ChangJiang Pharmaceutical
- 6.18.1 HEC ChangJiang Pharmaceutical Company Information
- 6.18.2 HEC ChangJiang Pharmaceutical Business Overview
- 6.18.3 HEC ChangJiang Pharmaceutical Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 HEC ChangJiang Pharmaceutical Drug Release Platform Product Portfolio
- 6.18.5 HEC ChangJiang Pharmaceutical Recent Developments
- 6.19 Luye Pharma
- 6.19.1 Luye Pharma Company Information
- 6.19.2 Luye Pharma Business Overview
- 6.19.3 Luye Pharma Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.19.4 Luye Pharma Drug Release Platform Product Portfolio
- 6.19.5 Luye Pharma Recent Developments
- 6.20 Lanna Bio
- 6.20.1 Lanna Bio Company Information
- 6.20.2 Lanna Bio Business Overview
- 6.20.3 Lanna Bio Drug Release Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.20.4 Lanna Bio Drug Release Platform Product Portfolio
- 6.20.5 Lanna Bio Recent Developments
7 North America
- 7.1 North America Drug Release Platform Market Size (2021-2032)
- 7.2 North America Drug Release Platform Market Size by Type
- 7.2.1 North America Drug Release Platform Market Size by Type (2021-2026)
- 7.2.2 North America Drug Release Platform Market Size by Type (2027-2032)
- 7.2.3 North America Drug Release Platform Market Share by Type (2021-2032)
- 7.3 North America Drug Release Platform Market Size by Application
- 7.3.1 North America Drug Release Platform Market Size by Application (2021-2026)
- 7.3.2 North America Drug Release Platform Market Size by Application (2027-2032)
- 7.3.3 North America Drug Release Platform Market Share by Application (2021-2032)
- 7.4 North America Drug Release Platform Market Size by Country
- 7.4.1 North America Drug Release Platform Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Drug Release Platform Market Size by Country (2021-2026)
- 7.4.3 North America Drug Release Platform Market Size by Country (2027-2032)
- 7.4.4 North America Drug Release Platform Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Drug Release Platform Market Size (2021-2032)
- 8.2 Europe Drug Release Platform Market Size by Type
- 8.2.1 Europe Drug Release Platform Market Size by Type (2021-2026)
- 8.2.2 Europe Drug Release Platform Market Size by Type (2027-2032)
- 8.2.3 Europe Drug Release Platform Market Share by Type (2021-2032)
- 8.3 Europe Drug Release Platform Market Size by Application
- 8.3.1 Europe Drug Release Platform Market Size by Application (2021-2026)
- 8.3.2 Europe Drug Release Platform Market Size by Application (2027-2032)
- 8.3.3 Europe Drug Release Platform Market Share by Application (2021-2032)
- 8.4 Europe Drug Release Platform Market Size by Country
- 8.4.1 Europe Drug Release Platform Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Drug Release Platform Market Size by Country (2021-2026)
- 8.4.3 Europe Drug Release Platform Market Size by Country (2027-2032)
- 8.4.4 Europe Drug Release Platform Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Drug Release Platform Market Size (2021-2032)
- 9.2 China Drug Release Platform Market Size by Type
- 9.2.1 China Drug Release Platform Market Size by Type (2021-2026)
- 9.2.2 China Drug Release Platform Market Size by Type (2027-2032)
- 9.2.3 China Drug Release Platform Market Share by Type (2021-2032)
- 9.3 China Drug Release Platform Market Size by Application
- 9.3.1 China Drug Release Platform Market Size by Application (2021-2026)
- 9.3.2 China Drug Release Platform Market Size by Application (2027-2032)
- 9.3.3 China Drug Release Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Drug Release Platform Market Size (2021-2032)
- 10.2 Asia Drug Release Platform Market Size by Type
- 10.2.1 Asia Drug Release Platform Market Size by Type (2021-2026)
- 10.2.2 Asia Drug Release Platform Market Size by Type (2027-2032)
- 10.2.3 Asia Drug Release Platform Market Share by Type (2021-2032)
- 10.3 Asia Drug Release Platform Market Size by Application
- 10.3.1 Asia Drug Release Platform Market Size by Application (2021-2026)
- 10.3.2 Asia Drug Release Platform Market Size by Application (2027-2032)
- 10.3.3 Asia Drug Release Platform Market Share by Application (2021-2032)
- 10.4 Asia Drug Release Platform Market Size by Country
- 10.4.1 Asia Drug Release Platform Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Drug Release Platform Market Size by Country (2021-2026)
- 10.4.3 Asia Drug Release Platform Market Size by Country (2027-2032)
- 10.4.4 Asia Drug Release Platform Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Drug Release Platform Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Drug Release Platform Market Size by Type
- 11.2.1 South America, Middle East & Africa Drug Release Platform Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Drug Release Platform Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Drug Release Platform Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Drug Release Platform Market Size by Application
- 11.3.1 South America, Middle East & Africa Drug Release Platform Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Drug Release Platform Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Drug Release Platform Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Drug Release Platform Market Size by Country
- 11.4.1 South America, Middle East & Africa Drug Release Platform Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Drug Release Platform Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Drug Release Platform Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Drug Release Platform Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst